PTGS2 and neoplasm: High levels of PGE2, a known contributor to the tumor microenvironment of CRC patients, have been previously attributed to increased synthesis through COX-2 up-regulation and more recently to decreased catabolism by 15-PGDH, which is down-regulated in many CRCs [29].